Navigation Links
LeMaitre Vascular, Inc. Schedules First Quarter Results and Conference Call
Date:4/18/2008

BURLINGTON, Mass., April 18 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that it will release its 2008 first quarter financial results on April 30, 2008, after the close of the market. In conjunction with the release, a conference call will be hosted the same day at 5:00 PM ET. The call will be broadcast simultaneously over the internet.

Interested participants may listen to the live webcast at http://www.lemaitre.com/investor, or dial in at 866-831-6247 (+1 617-213-8856 for international callers), using passcode 22576785. A replay of the call will be available at http://www.lemaitre.com/investor .

During the call, LeMaitre's senior management will provide an overview of the first quarter results, business highlights and company outlook.

About LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease. The Company's principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com .


'/>"/>
SOURCE LeMaitre Vascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. LeMaitre Vascular Announces Changes to Its Executive Management Team
2. LeMaitre Vascular Reports Q4 2007 Revenue of $11.1 Million, a 27% Increase
3. LeMaitre Vascular, Inc. Schedules Fourth Quarter Results and Conference Call
4. LeMaitre Vascular Launches Next-Generation Stent Graft Delivery System
5. LeMaitre Vascular to Participate at Canaccord Adams Inaugural Cardiovascular Conference
6. LeMaitre Vascular Reports Q3 2007 Revenue of $10.1 Million, a 19% Increase
7. LeMaitre Vascular to Participate at CIBC 18th Annual Healthcare Conference
8. LeMaitre Vascular to Start Italian Sales Force
9. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results
10. MSA Schedules First Quarter Earnings Webcast
11. Omnicell Schedules First Quarter 2008 Earnings Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... International Protein, ... nutritional and bodybuilding supplements, announced it attended the January ECRM trade show in Hilton ... and nutritional scientist who was determined to create a line of products that would ...
(Date:1/20/2017)... ... , ... “Mary Magdalene: Grace is Greater than Sin”: a unique and ... Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published ... with countless women who had little knowledge of the female characters portrayed in the ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... 19, 2017 , ... Next week after January 20th, the fear for many ... that circumvent health needs of over 30 million. Many interviews with Dr. Carol Francis ... government public servants were suppose to prioritize. Interviews provided below. , Among ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... 19, 2017  Stealth BioTherapeutics Inc. ( Stealth ), ... dysfunction, today announced new additions to its senior leadership ... Medical Officer, and Daniel Geffken as interim ... Jim Carr , Pharm.D. has been promoted to Chief ... to welcome Doug and Daniel to our management team, ...
(Date:1/19/2017)... January 19, 2017 According to a study ... is set to witness a CAGR of 6.5% during the forecast ... will continue to be the leading market for cryotherapy globally ... ... emphasizing on ensuring affordable and adequate supply of gas in order ...
Breaking Medicine Technology: